HOME >> MEDICINE >> NEWS
Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy

SAN ANTONIO -- Researchers at The University of Texas M. D. Anderson Cancer Center have developed two genomic tests to better predict how breast cancer patients will respond to chemotherapy or hormonal therapy.

In presentations Dec. 14-15 at the San Antonio Breast Cancer Symposium, the research team reports on a highly sensitive multiple-gene test designed to predict response to chemotherapy, performed before surgery at M.D. Anderson, and a genomic index that gauges 10-year survival for patients who receive post-operative hormonal therapy with the drug tamoxifen.

"We are moving these tests toward clinical trials, where we can measure improvements in treatment response and track how physicians and patients use this information to make better decisions about treatment," says one of the team leaders, Lajos Pusztai, M.D., Ph.D., associate professor in M. D. Anderson's Department of Breast Medical Oncology.

The team developed a multi-gene predictor for pathological complete response (absence of cancer after chemotherapy), by analyzing 82 women who received preoperative paclitaxel and fluorouracil-doxocrubicin-cyclophsophamide (T/FAC), the standard of care for chemotherapy. Pusztai says the team analyzed 780 different combinations before winnowing the test down to a small set of genes.

The test was then applied to 51 new patients who received identical T/FAC treatment. It accurately predicted 12 of 13 patients who achieved a complete response. Of the 28 patients the test predicted would have residual cancer, 27 had breast cancer after treatment, indicating a high negative predictive value. "That's important, because if you knew in advance that you were unlikely to benefit from this standard chemotherapy, then you might choose a different treatment or an investigational drug," Pusztai says.

The test also predicted that 23 patients would achieve complete response, when only 12 did, mainly because the remainder had
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
14-Dec-2006


Page: 1 2 3

Related medicine news :

1. National Academies advisory: Genomics Revolution Conference summary
2. Genomics researchers discover protein deficit that causes drug toxicity
3. Holograms make for better vision tests
4. Study tests oral insulin to prevent type 1 diabetes
5. Diagnostic tests for malaria underused in Zambia
6. UW study tests topical honey as a treatment for diabetic ulcers
7. Experimental flu vaccine appears promising in early tests
8. Light-based probe sees early cancers in first tests on human tissue
9. Study tests oral insulin to prevent type 1 diabetes
10. Rapid flu tests may reduce threat of antibiotic resistance
11. Prompting men to have syphilis tests

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... 2019 , ... Mount Sinai Health System is hosting a ... Nations Staff Recreation Council in support of the Helen Sawaya Fund, a philanthropic ... art, massage, and pet therapies to increase the comfort and emotional and mental ...
(Date:1/10/2019)... ... ... The Karis Group, an Austin, Texas based company, announced today that it has ... Mr. Jiwa succeeds the past Chief Executive Officer, Mike Martin, who retired from ... as part of an orderly succession plan and transition of leadership at the 22-year ...
(Date:1/8/2019)... ... ... West 10th Dental in New York, NY is pleased to announce the launch ... founder of West 10th Dental, "We want our patients to know that we are, ... up with the latest in technology as dentistry changes, and by making ourselves always ...
(Date:1/8/2019)... (PRWEB) , ... January 08, 2019 , ... In Partnership ... provide free dental services for low-income, underinsured individuals in Las Vegas, NV on February ... x-rays, fillings, cleanings and extractions. For more information, please visit the Smiles for Everyone ...
(Date:1/7/2019)... , ... January 07, 2019 , ... ... Course is now a candidate for accreditation from the American Society of ... nationwide. The organization’s 45,000 members include pharmacists, student pharmacists and pharmacy technicians. , ...
Breaking Medicine News(10 mins):
(Date:1/11/2019)... ... ... According to research, acupuncture can quickly and effectively treat sinusitis, allergy, and asthma ... the respiratory treatment they need at its Houston clinic. , “We don’t just treat ... Acupuncture and Chinese Medicine can treat a wide range of conditions,” said Sylvia He, ...
(Date:1/10/2019)... (PRWEB) , ... January 10, 2019 , ... ... to introduce the new A-Series Advantage Anesthesia Delivery platform, providing a modular, state-of-the-art ... A7 Advantage systems, enabling Mindray to continue its unwavering commitment to perioperative care. ...
(Date:1/8/2019)... ... January 08, 2019 , ... University Hospitals ... UroLift® Center of Excellence. The designation recognizes that Dr. Jaeger has achieved a ... commitment to exemplary care for men suffering from symptoms associated with benign prostatic ...
Breaking Medicine Technology:
Cached News: